302 related articles for article (PubMed ID: 33798773)
1. Compound- and fiber type-selective requirement of AMPKγ3 for insulin-independent glucose uptake in skeletal muscle.
Rhein P; Desjardins EM; Rong P; Ahwazi D; Bonhoure N; Stolte J; Santos MD; Ovens AJ; Ehrlich AM; Sanchez Garcia JL; Ouyang Q; Yabut JM; Kjolby M; Membrez M; Jessen N; Oakhill JS; Treebak JT; Maire P; Scott JW; Sanders MJ; Descombes P; Chen S; Steinberg GR; Sakamoto K
Mol Metab; 2021 Sep; 51():101228. PubMed ID: 33798773
[TBL] [Abstract][Full Text] [Related]
2. Direct small molecule ADaM-site AMPK activators reveal an AMPKγ3-independent mechanism for blood glucose lowering.
Jørgensen NO; Kjøbsted R; Larsen MR; Birk JB; Andersen NR; Albuquerque B; Schjerling P; Miller R; Carling D; Pehmøller CK; Wojtaszewski JFP
Mol Metab; 2021 Sep; 51():101259. PubMed ID: 34033941
[TBL] [Abstract][Full Text] [Related]
3. Benzimidazole derivative small-molecule 991 enhances AMPK activity and glucose uptake induced by AICAR or contraction in skeletal muscle.
Bultot L; Jensen TE; Lai YC; Madsen AL; Collodet C; Kviklyte S; Deak M; Yavari A; Foretz M; Ghaffari S; Bellahcene M; Ashrafian H; Rider MH; Richter EA; Sakamoto K
Am J Physiol Endocrinol Metab; 2016 Oct; 311(4):E706-E719. PubMed ID: 27577855
[TBL] [Abstract][Full Text] [Related]
4. Knockout of the alpha2 but not alpha1 5'-AMP-activated protein kinase isoform abolishes 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranosidebut not contraction-induced glucose uptake in skeletal muscle.
Jørgensen SB; Viollet B; Andreelli F; Frøsig C; Birk JB; Schjerling P; Vaulont S; Richter EA; Wojtaszewski JF
J Biol Chem; 2004 Jan; 279(2):1070-9. PubMed ID: 14573616
[TBL] [Abstract][Full Text] [Related]
5. Role of AMPKalpha2 in basal, training-, and AICAR-induced GLUT4, hexokinase II, and mitochondrial protein expression in mouse muscle.
Jørgensen SB; Treebak JT; Viollet B; Schjerling P; Vaulont S; Wojtaszewski JF; Richter EA
Am J Physiol Endocrinol Metab; 2007 Jan; 292(1):E331-9. PubMed ID: 16954334
[TBL] [Abstract][Full Text] [Related]
6. Muscle-specific overexpression of wild type and R225Q mutant AMP-activated protein kinase gamma3-subunit differentially regulates glycogen accumulation.
Yu H; Hirshman MF; Fujii N; Pomerleau JM; Peter LE; Goodyear LJ
Am J Physiol Endocrinol Metab; 2006 Sep; 291(3):E557-65. PubMed ID: 16638825
[TBL] [Abstract][Full Text] [Related]
7. Prolonged β
van Beek SMM; Kalinovich A; Schaart G; Bengtsson T; Hoeks J
Am J Physiol Endocrinol Metab; 2021 Mar; 320(3):E619-E628. PubMed ID: 33522400
[TBL] [Abstract][Full Text] [Related]
8. Adipose tissue-specific knockout of AMPKα1/α2 results in normal AICAR tolerance and glucose metabolism.
Choi RH; McConahay A; Johnson MB; Jeong HW; Koh HJ
Biochem Biophys Res Commun; 2019 Nov; 519(3):633-638. PubMed ID: 31540695
[TBL] [Abstract][Full Text] [Related]
9. Gain-of-function R225Q mutation in AMP-activated protein kinase gamma3 subunit increases mitochondrial biogenesis in glycolytic skeletal muscle.
Garcia-Roves PM; Osler ME; Holmström MH; Zierath JR
J Biol Chem; 2008 Dec; 283(51):35724-34. PubMed ID: 18838377
[TBL] [Abstract][Full Text] [Related]
10. Adenosine monophosphate-activated protein kinase is elevated in human cachectic muscle and prevents cancer-induced metabolic dysfunction in mice.
Raun SH; Ali MS; Han X; Henríquez-Olguín C; Pham TCP; Meneses-Valdés R; Knudsen JR; Willemsen ACH; Larsen S; Jensen TE; Langen R; Sylow L
J Cachexia Sarcopenia Muscle; 2023 Aug; 14(4):1631-1647. PubMed ID: 37194385
[TBL] [Abstract][Full Text] [Related]
11. Role of the AMPKgamma3 isoform in hypoxia-stimulated glucose transport in glycolytic skeletal muscle.
Deshmukh AS; Glund S; Tom RZ; Zierath JR
Am J Physiol Endocrinol Metab; 2009 Dec; 297(6):E1388-94. PubMed ID: 19826102
[TBL] [Abstract][Full Text] [Related]
12. AMP-activated protein kinase activation in skeletal muscle modulates exercise-induced uncoupled protein 1 expression in brown adipocyte in mouse model.
Kim HJ; Kim YJ; Seong JK
J Physiol; 2022 May; 600(10):2359-2376. PubMed ID: 35301717
[TBL] [Abstract][Full Text] [Related]
13. A Tbc1d1
Chen Q; Xie B; Zhu S; Rong P; Sheng Y; Ducommun S; Chen L; Quan C; Li M; Sakamoto K; MacKintosh C; Chen S; Wang HY
Diabetologia; 2017 Feb; 60(2):336-345. PubMed ID: 27826658
[TBL] [Abstract][Full Text] [Related]
14. PT-1 selectively activates AMPK-γ1 complexes in mouse skeletal muscle, but activates all three γ subunit complexes in cultured human cells by inhibiting the respiratory chain.
Jensen TE; Ross FA; Kleinert M; Sylow L; Knudsen JR; Gowans GJ; Hardie DG; Richter EA
Biochem J; 2015 May; 467(3):461-72. PubMed ID: 25695398
[TBL] [Abstract][Full Text] [Related]
15. Role of adenosine 5'-monophosphate-activated protein kinase in interleukin-6 release from isolated mouse skeletal muscle.
Glund S; Treebak JT; Long YC; Barres R; Viollet B; Wojtaszewski JF; Zierath JR
Endocrinology; 2009 Feb; 150(2):600-6. PubMed ID: 18818284
[TBL] [Abstract][Full Text] [Related]
16. Effects of alpha-AMPK knockout on exercise-induced gene activation in mouse skeletal muscle.
Jørgensen SB; Wojtaszewski JF; Viollet B; Andreelli F; Birk JB; Hellsten Y; Schjerling P; Vaulont S; Neufer PD; Richter EA; Pilegaard H
FASEB J; 2005 Jul; 19(9):1146-8. PubMed ID: 15878932
[TBL] [Abstract][Full Text] [Related]
17. ApoA-1 improves glucose tolerance by increasing glucose uptake into heart and skeletal muscle independently of AMPKα
Fritzen AM; Domingo-Espín J; Lundsgaard AM; Kleinert M; Israelsen I; Carl CS; Nicolaisen TS; Kjøbsted R; Jeppesen JF; Wojtaszewski JFP; Lagerstedt JO; Kiens B
Mol Metab; 2020 May; 35():100949. PubMed ID: 32244181
[TBL] [Abstract][Full Text] [Related]
18. Whole body deletion of AMP-activated protein kinase {beta}2 reduces muscle AMPK activity and exercise capacity.
Steinberg GR; O'Neill HM; Dzamko NL; Galic S; Naim T; Koopman R; Jørgensen SB; Honeyman J; Hewitt K; Chen ZP; Schertzer JD; Scott JW; Koentgen F; Lynch GS; Watt MJ; van Denderen BJ; Campbell DJ; Kemp BE
J Biol Chem; 2010 Nov; 285(48):37198-209. PubMed ID: 20855892
[TBL] [Abstract][Full Text] [Related]
19. AXIN1 knockout does not alter AMPK/mTORC1 regulation and glucose metabolism in mouse skeletal muscle.
Li J; Knudsen JR; Henriquez-Olguin C; Li Z; Birk JB; Persson KW; Hellsten Y; Offergeld A; Jarassier W; Le Grand F; Schjerling P; Wojtaszewski JFP; Jensen TE
J Physiol; 2021 Jun; 599(12):3081-3100. PubMed ID: 33913171
[TBL] [Abstract][Full Text] [Related]
20. Role of adenosine 5'-monophosphate-activated protein kinase subunits in skeletal muscle mammalian target of rapamycin signaling.
Deshmukh AS; Treebak JT; Long YC; Viollet B; Wojtaszewski JF; Zierath JR
Mol Endocrinol; 2008 May; 22(5):1105-12. PubMed ID: 18276828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
